Cargando…

The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant

This study aimed to estimate the distribution of hepatitis B virus (HBV) C/D recombinant in Han and Tibet patients with chronic hepatitis B (CHB) and then learn such strain's replication capacity in vivo. A total of 331 serum samples were collected from Han outpatients from Sichuan Province and...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lingyao, Liu, Menghan, Liu, Miao, Zhou, Taoyou, Cheng, Xing, Liu, Cong, Tang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497610/
https://www.ncbi.nlm.nih.gov/pubmed/28713830
http://dx.doi.org/10.1155/2017/8415907
_version_ 1783248178343051264
author Du, Lingyao
Liu, Menghan
Liu, Miao
Zhou, Taoyou
Cheng, Xing
Liu, Cong
Tang, Hong
author_facet Du, Lingyao
Liu, Menghan
Liu, Miao
Zhou, Taoyou
Cheng, Xing
Liu, Cong
Tang, Hong
author_sort Du, Lingyao
collection PubMed
description This study aimed to estimate the distribution of hepatitis B virus (HBV) C/D recombinant in Han and Tibet patients with chronic hepatitis B (CHB) and then learn such strain's replication capacity in vivo. A total of 331 serum samples were collected from Han outpatients from Sichuan Province and Tibetan outpatients from Tibet. Viral genotypes in these samples were identified. An HBV replicative plasmid of C/D recombinant was constructed with selected genome. Sequentially, HBV replicative mouse models were established and the replication capacity of the viral strain was studied in vivo. In the 314 Han patients, 66% (207) were infected by genotype B strain while 31% (96) were by genotype C strain. Only 1% (3) were by C/D recombinant. In the 17 Tibetan patients, 41% (7) were by genotype D and 35% (6) by C/D recombinant. A plasmid with 1.3 copies of C/D recombinant genome was constructed. And its replication intermediates were found at similar levels to that of genotype D strain. Thus, C/D recombinant, the dominant viral strain in Tibet, was rather rare in the genotype B predominated Han patients from Sichuan Province. And the C/D recombinant replicated at a similar level to viral strain of genotype D in vivo.
format Online
Article
Text
id pubmed-5497610
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-54976102017-07-16 The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant Du, Lingyao Liu, Menghan Liu, Miao Zhou, Taoyou Cheng, Xing Liu, Cong Tang, Hong Biomed Res Int Research Article This study aimed to estimate the distribution of hepatitis B virus (HBV) C/D recombinant in Han and Tibet patients with chronic hepatitis B (CHB) and then learn such strain's replication capacity in vivo. A total of 331 serum samples were collected from Han outpatients from Sichuan Province and Tibetan outpatients from Tibet. Viral genotypes in these samples were identified. An HBV replicative plasmid of C/D recombinant was constructed with selected genome. Sequentially, HBV replicative mouse models were established and the replication capacity of the viral strain was studied in vivo. In the 314 Han patients, 66% (207) were infected by genotype B strain while 31% (96) were by genotype C strain. Only 1% (3) were by C/D recombinant. In the 17 Tibetan patients, 41% (7) were by genotype D and 35% (6) by C/D recombinant. A plasmid with 1.3 copies of C/D recombinant genome was constructed. And its replication intermediates were found at similar levels to that of genotype D strain. Thus, C/D recombinant, the dominant viral strain in Tibet, was rather rare in the genotype B predominated Han patients from Sichuan Province. And the C/D recombinant replicated at a similar level to viral strain of genotype D in vivo. Hindawi 2017 2017-06-21 /pmc/articles/PMC5497610/ /pubmed/28713830 http://dx.doi.org/10.1155/2017/8415907 Text en Copyright © 2017 Lingyao Du et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Du, Lingyao
Liu, Menghan
Liu, Miao
Zhou, Taoyou
Cheng, Xing
Liu, Cong
Tang, Hong
The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant
title The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant
title_full The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant
title_fullStr The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant
title_full_unstemmed The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant
title_short The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant
title_sort prevalence and replication capacity of a tibetan dominant hbv strain, c/d recombinant
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497610/
https://www.ncbi.nlm.nih.gov/pubmed/28713830
http://dx.doi.org/10.1155/2017/8415907
work_keys_str_mv AT dulingyao theprevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT liumenghan theprevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT liumiao theprevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT zhoutaoyou theprevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT chengxing theprevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT liucong theprevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT tanghong theprevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT dulingyao prevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT liumenghan prevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT liumiao prevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT zhoutaoyou prevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT chengxing prevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT liucong prevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant
AT tanghong prevalenceandreplicationcapacityofatibetandominanthbvstraincdrecombinant